19 Nov 2023
The catheter-based treatment revolution is just getting started
Sponsored by Edwards Lifesciences
Anchorperson:
H. Eltchaninoff
Spokespersons:
P. Lurz, S. Windecker
Summary
Consult this session to stay updated on the latest advancements in transcatheter aortic valve implantations and interventions for tricuspid regurgitation. Gain insights into how recent evidence and innovations are reshaping the treatment landscape for valvular heart disease.
Learning Objectives
- To learn about the latest innovations related to transcatheter aortic valve implantations and tricuspid regurgitation interventions
- To understand how the latest evidence and innovations are changing the therapy of valvular heart disease
- To discuss the benefits of new technical solutions for patients with valvular heart disease
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)